Serum free thyroxine (FT 4 ) and thyroid hormone-binding protein concentrations were measured in pregnant women, stilboestrol-treated patients, and subjects with congenital thyroxinebinding-globulin (TBG) excess. In pregnant and stilboestrol-treated patients matched for TBG concentrations, serum Ff4 concentrations measured by the Amerlex technique and by calculation, were reduced, as also was the total thyroxine (TT 4)/TBG ratio. In congenital TBG excess Amerlex and calculated FT4 concentrations were normal whereas the TT 4/TBG ratio was low. In contrast to the Amerlex method, FT 4 concentrations by the Immophase procedure were normal in pregnant and stilboestrol-treated individuals and high in congenital TBG excess.
Subjects and methods
Venous blood was taken from 11 pregnant women during the third trimester of normal pregnancy (group 1), 11 men receiving stilboestrol for prostatic carcinoma (group 2), 8 euthyroid subjects with congenitally increased TBG concentrations (group 3), and 11 normal euthyroid control subjects (group 4) comprising 9 women and 2 men (mean age 33, range 22--44 years) . Subjects in groups 1 and 2 were matched with regard to serum TBG concentrations. Serum was stored at -20°C until assay, with samples from each subject group interspersed within each batch.
Total thyroxine (TT.) concentrations were measured by radioimmunoassay and TBG, prealbumin (PA) and albumin by immunoelectrophoresis." Amerlex FT. and Immophase FT4 were assayed according to the manufacturer's instructions; calculated FT. was derived from the mathematical model of Prince and Ramsden" using molecular weight and affinity constant data previously described." TI./TBG ratios were calculated by dividing the total thyroxine concentration by the TBG value. Statistical calculations were done using Student's t test for unpaired data. 285
Increased concentrations of circulating thyroxinebinding globulin (TBG) are a well-recognised cause of potential confusion when biochemical tests of thyroid function are being assessed. High TBG concentrations most commonly result from increased synthesis due to oestrogens, either physiologically in pregnancy or after exogenous oestrogen administration as with the oral contraceptive pill (OCP) or during treatment with synthetic oestrogens, for example, stilboestrol. Another less common cause is congenital elevation of TBG.! 2 In the past it has been widely assumed that such increases in TBG concentration in euthyroid subjects are associated with normal serum free thyroxine (FT.) concentrations. More recently, several reports have suggested that serum FT. concentrations fall during pregnancy.s" In this study we have compared measured and calculated FT. concentrations in pregnant women with male patients taking stilboestrol for prostatic carcinoma and with subjects having congenitally increased concentrations of TBG. Measurement of serum FT. concentrations by both the Arnerlex technique, which uses an undisclosed labelled T. analogue, and by the Imrnophase technique, a rate-reaction method, allowed us to compare results by these two methods in our patient groups. Ashwell, Hopton, and Harrop Mean (± SEM) concentrations of serum thyroxine-binding globulin (TBG), prealbumin (PA), albumin, and total thyroxine (IT.) and TT.ITBG ratios in the four patient groups Table) There was no difference in the TT, concentrations between the TBG-matched pregnant women and stilboestrol-treated patients, both groups having higher values than normal subjects. Mean TT,/TBG ratios were reduced to a similar extent in both these groups (43 % and 44 %. respectively). This ratio was also lower than normal in the subjects with congenital increase of TBG (mean reduction 29 %).
SERUM FT, CONCENTRATION There was reasonable agreement between Amerlex and calculated FT, concentrations in the four subject groups (r = O· 76; p<O·OOI), with significantly lower values by both methods in the pregnant and stilboestrol-treated groups (see Figure) . The mean % reductions from normal in the pregnant and stilboestrol-treated patients were 42 % Rnd 41 % for Amerlex F'T, with corresponding figures of 29% and 30% for calculated FT,. Immunophase FT. concentrations were slightly higher than normal in the pregnant and stilboestrol-treated patients, but the differences were not significant.
In the subjects in group 3 with congenitally increased TBG concentrations, Amerlex and calculated FT, concentrations were not significantly different from their respective normal values. Immophase FT, concentrations, however, were higher than normal in group 3 subjects. .... (FT,) 
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Discussion Several recent studies have suggested that serum FT, concentrations fall in pregnancy. These studies have used differing FT, methodologies, for example, RIA-dialysis. 3 Amerlex-Ff', kit,' 6 symmetric rate dialysis" and calculation," The extent of reduction in the stilboestrol-treated patients noted in this study agrees with that observed in pregnancy. The TT,/TBG ratio also fell in both patient groups. Changes in thyroxine-binding proteins after stilboestrol treatment were first described by Dowling et al. 9 We are not aware of any detailed studies of FT, concentrations in stilboestrol-treated patients, but a reduction in TI,/TBG ratio has been noted." Our finding of a similar fall in FT, concentration by Amerlex and calculation at equivalent concentrations of TBG in the stilboestrol-treated patients and those in normal pregnancy suggest that oestrogens in pregnancy, rather than some other factor, are ultimately responsible for the reduced FT, concentrations. Although severe intercurrent illness may lead to marked changes in serum thyroid hormone concentrations.P we felt that this was not a major confounding factor in the prostatic carcinoma group because, at the time of assessment, the subjects were ambulant and attending as outpatients. The explanation of the lowered FT, concentrations after exposure to oestrogens is unclear; conceivably the differences could be related to changes in tissue sensitivity to thyroid hormones, to alterations in capillary permeability of thyroid hormones, or to haemodynamic changes, (eg, perfusion rates), either generally or in particular organs. Some of these concepts, together with discussion of a possible role for TBG in determining thyroid hormone tissue delivery, have recently been presented by Ekins. 12 In view of the essentially normal FT, concentrations (by Amerlex and calculation) in euthyroid subjects with congenitally high TBG concentrations it seems unlikely that the low FT, concentrations associated with pregnancy and stilboestrol therapy are related to the increased concentration of TBG alone. Our observation of a lower than normal TT,/TBG ratio in subjects with congenitally high TBG agrees with data reported by Burr et al. 2 ;  these workers described reduced PA concentration in congenitally high TBG, which was not confirmed in the present study. Immophase FT, results did not agree with calculated and Arnerlex FT, when TBG concentrations are raised. Normal Immophase FT, concentrations have previously been reported in pregnancy;613 normal FT, levels are also seen in patients taking stilboestrol, whereas apparently increased concentrations are seen in congenitally high TBG.
Theoretical limitations of the Corning Immophase FT, have been discussed previously.P 15 The discrepancy between Immophase FT, and calculated FT, suggests that the Imrnophase FT, method in tis present form gives erroneous results in high TBG situations. Calculated and Amerlex FT, methods therefore confirm normal FT, concentrations in congenital TBG excess. However, the fall in FT, concentration that occurs in pregnancy and during stilboestrol therapy opens an intriguing area for further study into physiological relationships of free and bound hormones and hormone-binding proteins.
